Q3 2025 Earnings Call Transcript November 10, 2025 Starwood Property Trust, Inc. misses on earnings expectations. Reported ...

President Lee Jae-myung’s remark that South Korea’s R&D success rate exceeds 90% has drawn criticism from parts of the scientific community, which called it “unverified and incomplete information.” ...

TSX: DIAM                                                                                                                  ...

Pfizer Inc. acquires Metsera, Inc., beating Novo Nordisk, for up to $86.25/share. Click for my analysis of the deal and what ...

Mark R. Ludwikowski and Laura M. Quesada of Clark Hill PLC examine how new tariffs on trucks signal the evolution of Section 232 from a national security safeguard into a broader instrument of U.S.

Investors in the Invesco QQQ Trust ETF are now effectively paying a multiple of 59x. Click here to read more about QQQ ETF.

Aligned with U.S Food and Drug Administration (FDA) on design of planned Phase 3 clinical trial of neflamapimod in patients with dementia with ...

Gross margins in the third quarter of 2025 were approximately 48.5%, versus 54.9% in the third quarter of 2024; and non-GAAP ...

Interactions with FDA Progressing Towards December 26, 2025 PDUFA Date for Aficamten; U.S. Commercial Launch Preparations on Track ...

Sandvik Rock Processing, through distributor S&R Enterprises, has introduced the first fully electric Sandvik mobile crushing ...

Theravance Biopharma, Inc. ("Theravance Biopharma" or the "Company") (NASDAQ: TBPH) today reported financial and operational results for the third quarter of 2025.